Personal tools

Coexpression cluster:C2809: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C2809_cerebellum_neuroectodermal_Monocytederived_Macrophage_carcinoid_Neural_neuroblastoma |id=C2809 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C2809_cerebellum_neuroectodermal_Monocytederived_Macrophage_carcinoid_Neural_neuroblastoma
|full_id=C2809_cerebellum_neuroectodermal_Monocytederived_Macrophage_carcinoid_Neural_neuroblastoma
|id=C2809
|id=C2809
|ontology_enrichment_celltype=CL:0002087!3.05e-13!119;CL:0000738!3.57e-13!140;CL:0002031!1.08e-12!124;CL:0002057!2.17e-12!42;CL:0000839!2.20e-11!70;CL:0000557!9.35e-11!71;CL:0000766!9.97e-11!76;CL:0002194!1.78e-10!63;CL:0000576!1.78e-10!63;CL:0000040!1.78e-10!63;CL:0000559!1.78e-10!63;CL:0000860!2.56e-10!45;CL:0002009!1.69e-09!65;CL:0000037!8.14e-08!172;CL:0000566!8.14e-08!172;CL:0000988!3.52e-07!182;CL:0002032!6.50e-07!165;CL:0000837!6.50e-07!165
|ontology_enrichment_disease=DOID:171!6.76e-07!10
|ontology_enrichment_uberon=UBERON:0000073!6.09e-37!94;UBERON:0001016!6.09e-37!94;UBERON:0005743!2.79e-35!86;UBERON:0001017!6.78e-35!82;UBERON:0001049!2.64e-32!57;UBERON:0005068!2.64e-32!57;UBERON:0006241!2.64e-32!57;UBERON:0007135!2.64e-32!57;UBERON:0002616!3.38e-30!59;UBERON:0000955!8.13e-29!69;UBERON:0006238!8.13e-29!69;UBERON:0002346!1.01e-27!90;UBERON:0002780!1.39e-25!41;UBERON:0001890!1.39e-25!41;UBERON:0006240!1.39e-25!41;UBERON:0003075!2.11e-25!86;UBERON:0007284!2.11e-25!86;UBERON:0003080!2.56e-24!42;UBERON:0007023!8.25e-24!115;UBERON:0002020!1.93e-21!34;UBERON:0003528!1.93e-21!34;UBERON:0001893!2.30e-21!34;UBERON:0003056!2.46e-21!61;UBERON:0002791!8.68e-21!33;UBERON:0001869!3.98e-20!32;UBERON:0000153!1.70e-17!129;UBERON:0007811!1.70e-17!129;UBERON:0000924!5.26e-17!173;UBERON:0006601!5.26e-17!173;UBERON:0000956!2.76e-16!25;UBERON:0000203!2.76e-16!25;UBERON:0000033!8.90e-16!123;UBERON:0004121!2.42e-15!169;UBERON:0002619!7.36e-15!22;UBERON:0002390!8.11e-14!102;UBERON:0003061!8.11e-14!102;UBERON:0001950!1.44e-13!20;UBERON:0002193!1.08e-10!112;UBERON:0002371!9.21e-10!80;UBERON:0001474!1.35e-09!86;UBERON:0003076!4.77e-09!15;UBERON:0003057!4.77e-09!15;UBERON:0004732!4.90e-08!13;UBERON:0004765!8.16e-08!101;UBERON:0001434!8.16e-08!101;UBERON:0004733!1.95e-07!12;UBERON:0002028!1.95e-07!12;UBERON:0007277!1.95e-07!12
}}
}}

Revision as of 14:28, 21 May 2012


Full id: C2809_cerebellum_neuroectodermal_Monocytederived_Macrophage_carcinoid_Neural_neuroblastoma



Phase1 CAGE Peaks

Hg19::chr5:147007238..147007242,-p@chr5:147007238..147007242
-
Hg19::chr5:147162202..147162227,-p2@JAKMIP2
Hg19::chr5:147162247..147162262,-p4@JAKMIP2
Hg19::chr5:147162263..147162332,-p1@JAKMIP2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
regional part of nervous system6.09e-3794
nervous system6.09e-3794
central nervous system6.78e-3582
neural tube2.64e-3257
neural rod2.64e-3257
future spinal cord2.64e-3257
neural keel2.64e-3257
regional part of brain3.38e-3059
brain8.13e-2969
future brain8.13e-2969
neurectoderm1.01e-2790
regional part of forebrain1.39e-2541
forebrain1.39e-2541
future forebrain1.39e-2541
neural plate2.11e-2586
presumptive neural plate2.11e-2586
anterior neural tube2.56e-2442
adult organism8.25e-24115
gray matter1.93e-2134
brain grey matter1.93e-2134
telencephalon2.30e-2134
pre-chordal neural plate2.46e-2161
regional part of telencephalon8.68e-2133
cerebral hemisphere3.98e-2032
anterior region of body1.70e-17129
craniocervical region1.70e-17129
ectoderm5.26e-17173
presumptive ectoderm5.26e-17173
cerebral cortex2.76e-1625
pallium2.76e-1625
head8.90e-16123
ectoderm-derived structure2.42e-15169
regional part of cerebral cortex7.36e-1522
hematopoietic system8.11e-14102
blood island8.11e-14102
neocortex1.44e-1320
hemolymphoid system1.08e-10112
bone marrow9.21e-1080
bone element1.35e-0986
posterior neural tube4.77e-0915
chordal neural plate4.77e-0915
segmental subdivision of nervous system4.90e-0813
skeletal element8.16e-08101
skeletal system8.16e-08101
segmental subdivision of hindbrain1.95e-0712
hindbrain1.95e-0712
presumptive hindbrain1.95e-0712
Disease
Ontology termp-valuen
neuroectodermal tumor6.76e-0710


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.